KMC Systems Introduces KMC 360 Program of Contract Design, Manufacture and Maintenance Services
News Jun 12, 2009
Elbit Systems of America’s KMC Systems introduces KMC 360, the company’s complete program for contract design, manufacture and maintenance. The program is designed to support OEMs and start-ups throughout the entire medical device and instrumentation product lifecycle by centralizing all outsourcing support.
The company’s process streamlines communication, strengthens product quality and results in time-to-market advantages.
“Relying on multiple partners throughout a product’s lifecycle can result in market launch delays, increased costs and inefficiencies,” said Patrick W. McNallen, President, KMC Systems. “Just as a circle is all encompassing, so too is KMC Systems’ portfolio of services. Our customers work with one partner that has the relevant experience and skill set to develop, produce and maintain complex medical devices and instrumentation.”
KMC 360 helps medical companies bring quality products to market on time and on budget as well as reduce manufacturing and field service costs, which is especially critical in times of economic difficulty. The company’s approach is based on defined and proven processes, continual communication and cross-functional collaboration throughout each of the product lifecycle stages.
By allowing companies to work with one experienced partner, KMC 360 smoothes product transitions from design to manufacture, avoiding costly redesigns and delays. It also enhances field maintenance support by allowing end users to leverage KMC Systems’ intimate design knowledge of their systems gained through the design and manufacturing stages.
KMC Systems’ integrated process is ideal for in-vitro diagnostic, surgical, therapeutic and lab automation applications. The company utilizes its multidisciplinary expertise and 30 years of experience to produce and maintain high-quality, complex medical systems such as clinical chemistry analyzers, surgical irrigation pumps, hemodialysis instruments and therapeutic cell processors.
Novel Chemistry Technique Simplifies Late-Stage Modification of Drug CompoundsNews
Chemists at The Scripps Research Institute (TSRI) have invented a technique that overcomes a long-standing problem in organic chemistry and should streamline the process of discovery and development for many new drugs.READ MORE
Elpis BioMed Closes Funding Round to Commercialise Novel Technology Platform for Generating Human Cell TypesNews
New Cambridge spin-out company commercialises disruptive technology that enables rapid generation of pure and consistent batches of human cell types. Geographically diversified, top-tier investor team includes key industry leaders to support early company development.READ MORE
Quotient Sciences Acquires Pharmaterials, a UK-based Contract Development and Manufacturing OrganizationNews
Quotient Sciences, the drug development services organization, announces it has acquired Pharmaterials, a contract development and manufacturing organization (CDMO) based in Reading, U.K..READ MORE